-- Fourth quarter worldwide volume growth of 16.1 percent, with increases in each of its six regions compared to the prior year period.
-- Fourth quarter EPS of $1.31 increased 33.7 percent compared to the adjusted1 EPS from prior year period.
-- Raises FY'11 EPS guidance to a range of $5.15 to $5.40.
-- Annual sales leader retention increased to 48.9 percent compared to 43.0 percent in the prior year.
-- Board of directors approved $0.25 quarterly dividend.
-- Board of directors approved stock split pending shareholder approval.
LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE:HLF) today reported that fourth quarter net sales increased 17 percent and local currency net sales increased 19 percent compared to the same time period in 2009. Net income for the quarter of $81.0 million, or $1.31 per diluted share compares to 2009 fourth quarter adjusted1 net income and EPS of $61.7 million and $0.98, respectively.
For the twelve months ended December 31, 2010, the company reported record net sales of $2.7 billion, an 18 percent increase on 14 percent volume growth compared to 2009. For the same period, the company's reported adjusted1 net income of $297.0 million, or $4.77 per diluted share improved 43 percent and 45 percent respectively compared to the adjusted1 2009 results of $207.1 million or $3.28 per diluted share. On a reported basis, EPS of $4.67 increased 45 percent compared to 2009.
The full year improvements in earnings were predominantly a result of strong volume growth. For the second consecutive quarter and for the year ended December 31, 2010, as compared to full year 2009, each of the company's six regions experienced volume growth. "The continued broad-based growth we are experiencing further confirms the strength of the business methods our Distributors are using," said Chairman and Chief Executive Officer Michael O. Johnson. "Our nutrition products have never been more relevant, our Distributors' engagement has never been higher and their methods are reaching more consumers every day."
For the year ended December 31, 2010, the company generated cash flow from operations of $380.4 million, an increase of 33.4 percent compared to 2009, paid dividends of $53.7 million, invested $68.1 million in capital expenditures and repurchased $150.1 million in common shares as part of its $1 billion share repurchase authorization program. The company has reduced its net debt by $111.9 million from December 2009 levels.
1See Schedule B - "Reconciliation of Non-GAAP Financial Measures" for more detail.
Fourth Quarter and Full Year 2010 Regional Key Metrics2,3
Regional Volume Point and Average Active Sales Leader Metrics
Volume Points (Mil) Avg Active Sales Leaders
Region 4Q'10 Yr/Yr % FY'10 Yr/Yr % 4Q'10 Yr/Yr %
Chg Chg Chg
North America 200.2 8.0 % 888.5 13.9 % 51,174 13.0 %
Asia Pacific 188.0 23.6 % 723.6 26.8 % 39,531 22.7 %
EMEA 125.3 8.5 % 486.6 4.3 % 35,552 5.4 %
Mexico 154.8 26.5 % 563.0 14.1 % 41,485 15.7 %
South & Central 122.9 12.5 % 427.4 3.7 % 31,348 5.8 %
America
China 38.0 29.3 % 144.2 25.1 % 7,851 31.3 %
Worldwide Total 829.2 16.1 % 3,233.3 13.9 % 202,178 14.4 %
Volume Points (Mil) Avg Active Sales Leaders
4Q'10 Yr/Yr % FY'10 Yr/Yr % 4Q'10 Yr/Yr %
Chg Chg Chg
Emerging Markets 457.2 19.3 % 1,677.6 12.5 % 112,715 20.4 %
Established Markets 372.0 12.5 % 1,555.7 15.6 % 93,301 13.1 %
Worldwide Total 829.2 16.1 % 3,233.3 13.9 % 202,178 14.4 %
2 "Emerging markets" are defined herein as those countries that the World Bank categorized as having "low" or "medium" GDP per capita, while "Established markets" are defined as those countries categorized by the World Bank as having "high" GDP per capita.
3 Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com
2010 Annual Sales Leader Requalification
By January of each year, sales leaders are required to re-qualify. In February of each year, we remove from the rank of sales leaders those individuals who did not satisfy the sales leader qualification requirements during the preceding 12-months. For the latest 12-month re-qualification period ending January 2011, 48.9 percent of the eligible sales leaders re-qualified, reflecting an improvement from 43.0 percent in 2009.
Updated 2011 Guidance
Based on current business trends and foreign currency rates, the company's first quarter and fiscal 2011 guidance is provided below.
First Quarter - The company's first quarter 2011 diluted earnings per share guidance range is $1.17 to $1.21 on volume point growth of 14.0 percent to 16.0 percent and net sales growth of 18.0 percent to 20.0 percent compared to the same period in 2010, respectively, and an effective tax rate range of 28.0 percent to 29.0 percent. The company's first quarter 2011 capital expenditures are expected to be in the range of $18.0 million to $23 million.
Fiscal 2011 - The company's fiscal 2011 diluted earnings per share guidance range is $5.15 to $5.40 on volume point growth of 8.0 percent to 10.0 percent and net sales growth of 13.0 percent to 15.0 percent compared to the same period in 2010, respectively, and an effective tax rate range of 28.0 percent to 29.0 percent. The company's fiscal 2011 capital expenditures are expected to be in the range of $80.0 million to $90.0 million.
Board of Directors Approved Stock Split
The Herbalife Board of Directors has approved a two-for-one split of Herbalife's Common Shares, subject to shareholder approval. If approved by the shareholders, the stock split would be effected by the subdivision of each outstanding Common Share of a par value of $0.002 each into two Common Shares of a par value of $0.001 each and a proportional amendment of the authorized share capital. Shareholder approval of the stock split will be sought by the company during its annual general meeting of Shareholders which will be held on April 28, 2011.
"We are pleased to announce this pending two-for-one stock split," said John DeSimone, chief financial officer at Herbalife. "This decision by the board of directors acknowledges our track record of providing our shareholders solid long-term returns and demonstrates our confidence in the company's positive outlook for future growth. We believe that the pending stock split will improve liquidity in our stock and is representative of our ongoing commitment to shareholder value." The Board of Directors established May 10, 2011, as the record date for the stock split. Each shareholder of record as of the close of business on the record date will receive one additional Common Share for every share held. The new shares will be distributed on or about May 17, 2011.
Announces Quarterly Dividend
The company reported today that its board of directors approved a $0.25 per share dividend to shareholders of record effective March 8, 2011 payable on March 22, 2011.
Fourth Quarter Earnings Conference Call
Herbalife's senior management team will host an investor conference call Wednesday, February 23, 2011 at 11 a.m. EST (8 a.m. PST) to discuss its recent financial results and provide an update on current business trends.
The dial-in number for this conference call for domestic callers is 866.903.5314 and 706.634.5671 for international callers (conference ID 82536023). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.
An audio replay will be available following the completion of the conference call in MP3 format or by dialing 800.642.1687 for domestic callers or 706.645.9291 for international callers (conference ID 82536023). The webcast of the teleconference will be archived and available on Herbalife's website.
About Herbalife Ltd.
Herbalife Ltd. (NYSE:HLF) is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 75 countries through a network of approximately 2.1 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains a significant amount of information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.
FORWARD-LOOKING STATEMENTS
This document contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words "may," "will," "estimate," "intend," "continue," "believe," "expect" or "anticipate" and any other similar words.
Although we believe that expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:
-- any collateral impact resulting from the ongoing worldwide financial
"crisis," including the availability of liquidity to us, our customers
and our suppliers or the willingness of our customers to purchase
products in a recessionary economic environment;
-- our relationship with, and our ability to influence the actions of, our
distributors;
-- improper action by our employees or distributors in violation of
applicable law;
-- adverse publicity associated with our products or network marketing
organization;
-- changing consumer preferences and demands;
-- our reliance upon, or the loss or departure of any member of, our senior
management team which could negatively impact our distributor relations
and operating results;
-- the competitive nature of our business;
-- regulatory matters governing our products, including potential
governmental or regulatory actions concerning the safety or efficacy of
our products and network marketing program, including the direct selling
market in which we operate;
-- third party legal challenges to our network marketing program;
-- risks associated with operating internationally and the effect of
economic factors, including foreign exchange, inflation, disruptions or
conflicts with our third-party importers, pricing and currency
devaluation risks, especially in countries such as Venezuela;
-- uncertainties relating to the application of transfer pricing, duties,
value added taxes, and other tax regulations, and changes thereto;
-- uncertainties relating to interpretation and enforcement of recently
enacted legislation in China governing direct selling;
-- our inability to obtain the necessary licenses to expand our direct
selling business in China;
-- adverse changes in the Chinese economy, Chinese legal system or Chinese
governmental policies;
-- our dependence on increased penetration of existing markets;
-- contractual limitations on our ability to expand our business;
-- our reliance on our information technology infrastructure and outside
manufacturers;
-- the sufficiency of trademarks and other intellectual property rights;
-- product concentration;
-- changes in tax laws, treaties or regulations, or their interpretation;
-- taxation relating to our distributors;
-- product liability claims; and
-- whether we will purchase any of our shares in the open market or
otherwise.
We do not undertake any obligation to update or release any revisions to any forward-looking statements or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
RESULTS OF OPERATIONS:
Herbalife Ltd.
Consolidated Statements of Income
(In thousands, except per share data)
(unaudited)
Quarter Ended Year Ended
12/31/2010 12/31/2009 12/31/2010 12/31/2009
North America $ 140,898 $ 126,715 $ 614,126 $ 529,009
Mexico 97,716 69,132 333,981 263,013
South and Central 121,277 113,223 390,433 366,925
America
EMEA 140,146 130,932 527,744 504,154
Asia Pacific 189,081 151,468 683,499 509,191
China 49,238 39,401 184,443 152,285
Worldwide net sales 738,356 630,871 2,734,226 2,324,577
Cost of Sales 148,513 136,515 558,811 493,134
Gross Profit 589,843 494,356 2,175,415 1,831,443
Royalty Overrides 244,088 204,580 900,248 761,501
SGA 239,512 205,691 887,655 773,911
Operating Income 106,243 84,085 387,512 296,031
Interest Expense 1,944 1,836 9,664 9,613
Interest Income 818 820 2,247 4,510
Income before income 105,117 83,069 380,095 290,928
taxes
Income Taxes 24,127 27,413 89,562 87,582
Net Income 80,990 55,656 290,533 203,346
Basic Shares 59,082 60,492 59,502 61,221
Diluted Shares 62,058 63,004 62,256 63,097
Basic EPS $ 1.37 $ 0.92 $ 4.88 $ 3.32
Diluted EPS $ 1.31 $ 0.88 $ 4.67 $ 3.22
Dividends declared per $ 0.25 $ 0.20 $ 0.90 $ 0.80
share
Herbalife Ltd.
Consolidated Balance Sheets
(In thousands)
(unaudited)
Dec 31, Dec 31,
2010 2009
ASSETS
Current Assets:
Cash & cash equivalents $ 190,550 $ 150,801
Receivables, net 85,612 76,958
Inventories 182,467 145,962
Prepaid expenses and other current assets 93,963 101,181
Deferred income taxes 42,994 38,600
Total Current Assets 595,586 513,502
Property, plant and equipment, net 177,427 178,009
Deferred compensation plan assets 18,536 17,410
Deferred financing cost, net 998 1,498
Other assets 25,880 21,306
Marketing related intangibles and other intangible 310,894 311,782
assets, net
Goodwill 102,899 102,543
Total Assets $ 1,232,220 $ 1,146,050
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 43,784 $ 37,330
Royalty Overrides 162,141 144,689
Accrued compensation 69,376 65,043
Accrued expenses 141,867 107,943
Current portion of long term debt 3,120 12,402
Advance sales deposits 35,145 22,261
Income taxes payable 15,383 40,298
Total Current Liabilities 470,816 429,966
Non-current liabilities
Long-term debt, net of current portion 175,046 237,931
Deferred compensation 20,167 16,629
Deferred income taxes 55,572 77,613
Other non-current liabilities 23,407 24,600
Total Liabilities 745,008 786,739
Commitments and Contingencies
Shareholders' equity:
Common shares 118 120
Additional paid in capital 257,375 222,882
Accumulated other comprehensive loss (27,285 ) (23,396 )
Retained earnings 257,004 159,705
Total Shareholders' Equity 487,212 359,311
Total Liabilities and Shareholders' Equity $ 1,232,220 $ 1,146,050
Herbalife Ltd.
Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
Year Ended
12/31/2010 12/31/2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 290,533 $ 203,346
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization 68,621 62,437
Excess tax benefits from share-based payment (16,410 ) (3,266 )
arrangements
Share based compensation expenses 22,969 20,907
Amortization of discount and deferred financing 500 491
costs
Deferred income taxes (24,631 ) (11,226 )
Unrealized foreign exchange transaction loss (7,142 ) 4,809
(gain)
Foreign exchange loss from adoption of highly 15,131 --
inflationary accounting in Venezuela
Other 2,527 340
Changes in operating assets and liabilities:
Receivables (7,593 ) 2,361
Inventories (31,516 ) (1,742 )
Prepaid expenses and other current assets 10,254 (7,781 )
Other assets (3,485 ) 2,109
Accounts payable 6,650 (9,500 )
Royalty overrides 15,732 9,102
Accrued expenses and accrued compensation 31,092 (3,461 )
Advance sales deposits 12,439 8,779
Income taxes payable (8,807 ) 4,700
Deferred compensation plan liability 3,538 2,651
NET CASH PROVIDED BY OPERATING ACTIVITIES 380,402 285,056
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (68,125 ) (59,768 )
Proceeds from sale of property, plant and 115 102
equipment
Deferred compensation plan assets (1,126 ) (1,656 )
Acquisition of business - (10,000 )
NET CASH USED IN INVESTING ACTIVITIES (69,136 ) (71,322 )
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends paid (53,740 ) (48,721 )
Borrowings from long-term debt 427,000 211,974
Principal payments on long-term debt (499,451 ) (313,089 )
Share repurchases (160,008 ) (74,641 )
Excess tax benefits from share-based payment 16,410 3,266
arrangements
Proceeds from exercise of stock options and sale 15,309 7,884
of stock under employee stock purchase plan
NET CASH USED IN FINANCING ACTIVITIES (254,480 ) (213,327 )
EFFECT OF EXCHANGE RATE CHANGES ON CASH (17,037 ) (453 )
NET CHANGE IN CASH AND CASH EQUIVALENTS 39,749 (46 )
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 150,801 150,847
CASH AND CASH EQUIVALENTS, END OF YEAR $ 190,550 $ 150,801
CASH PAID DURING THE PERIOD
Interest paid $ 9,295 $ 10,011
Income taxes paid $ 111,497 $ 95,139
NON CASH ACTIVITIES
Assets acquired under capital leases and other $ 576 $ 388
long-term debt
Regional Volume Point and Average Active Sales Leader Metrics - 4Q'10 & FY'10
Volume Points (Mil) Average Active Sales Leaders
Yr/Yr Yr/Yr % Yr/Yr % Yr/Yr %
Region 4Q'10 % FY'10 Chg 4Q'10 Chg FY'10 Chg
Chg
North 200.2 8.0 % 888.5 13.9 % 51,174 13.0 % 49,305 13.9 %
America
Asia 188.0 23.6 % 723.6 26.8 % 39,531 22.7 % 35,899 25.8 %
Pacific
EMEA 125.3 8.5 % 486.6 4.3 % 35,552 5.4 % 33,531 2.9 %
Mexico 154.8 26.5 % 563.0 14.1 % 41,485 15.7 % 38,084 10.2 %
South &
Central 122.9 12.5 % 427.4 3.7 % 31,348 5.8 % 28,821 3.2 %
America
China 38.0 29.3 % 144.2 25.1 % 7,851 31.3 % 6,848 15.7 %
Worldwide 829.2 16.1 % 3,233.3 13.9 % 202,178 14.4 % 185,774 11.5 %
Total
Volume Points (Mil) Average Active Sales Leaders
Yr/Yr Yr/Yr % Yr/Yr % Yr/Yr %
4Q'10 % FY'10 Chg 4Q'10 Chg FY'10 Chg
Chg
Emerging 457.2 19.3 % 1,677.6 12.5 112,715 20.4 % 102,782 22.6 %
Markets
Established 372.0 12.5 % 1,555.7 15.6 93,301 13.1 % 88,137 31.3 %
Markets
Worldwide 829.2 16.1 % 3,233.3 13.9 % 202,178 14.4 % 185,774 11.5 %
Total
SUPPLEMENTAL INFORMATION
Schedule A: Financial Guidance
2011 Guidance
For the Three Months Ending March 31, 2011 and Twelve Months Ending December 31, 2011
Three Months Ending Twelve Months Ending
March 31, 2011 December 31, 2011
Low High Low High
Volume point growth vs 2010 14.0 % 16.0 % 8.0 % 10.0 %
Net sales growth vs 2010 18.0 % 20.0 % 13.0 % 15.0 %
EPS $ 1.17 $ 1.21 $ 5.15 $ 5.40
Cap Ex ($ millions) $ 18.0 $ 23.0 $ 80.0 $ 90.0
Effective Tax Rate 28.0 % 29.0 % 28.0 % 29.0 %
SCHEDULE B: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(unaudited), (Dollars in Thousand, Except Per Share Data)
In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as "non-GAAP financial measures." Management believes that such non-GAAP financial measures, when read in conjunction with the Company's reported results, can provide useful supplemental information for investor in analyzing period to period comparisons of the Company's results.
The following is a reconciliation of net income and diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:
Herbalife Ltd.
Supplemental Schedule
Non-GAAP Financial Measures
(In thousands, except per share data)
(Unaudited)
Quarter Ended 12/31/2010
Reported Adjusting Adjusted
(GAAP) Items (Non-GAAP)
Net Sales $ 738,356 $ 738,356
Cost of Sales 148,513 148,513
Gross Profit 589,843 589,843
Royalty Overrides 244,088 244,088
SGA 239,512 239,512
Operating Income 106,243 106,243
Interest Expense - net 1,126 1,126
Income before income taxes 105,117 105,117
Income Taxes 24,127 24,127
Net Income $ 80,990 $ - $ 80,990
Diluted EPS $ 1.31 $ - $ 1.31
Herbalife Ltd.
Supplemental Schedule
Non-GAAP Financial Measures
(In thousands, except per share data)
(Unaudited)
Twelve Months Ended 12/31/2010
Reported Adjusting Adjusted
(GAAP) Items (Non-GAAP)
Net Sales $ 2,734,226 $ 2,734,226
Cost of Sales 558,811 $ (12,715 ) (1) 546,096
Gross Profit 2,175,415 12,715 2,188,130
Royalty Overrides 900,248 900,248
SGA 887,655 (11,390 ) (2) 876,265
Operating Income 387,512 24,105 411,617
Interest Expense - net 7,417 7,417
Income before income taxes 380,095 24,105 404,200
Income Taxes 89,562 17,680 (3) 107,242
Net Income $ 290,533 $ 6,425 $ 296,958
Diluted EPS $ 4.67 $ 0.10 $ 4.77
1 Incremental U.S. dollar costs of 2009 imports in Venezuela which were
recorded at the unfavorable parallel market exchange rate and were not
devalued based on 2010 exchange rates but rather recorded at their
historical dollar costs as products were sold
2 Includes $15,131 foreign exchange loss related to remeasurement of
Venezuela's monetary assets and liabilities resulting from adoption of
highly inflationary accounting and $3,741 foreign exchange gain
resulting from receipt of U.S. dollar approved by CADIVI at the
official exchange rate relating to 2009 product importations which were
previously registered with CADIVI
3 Includes $14,452 favorable income taxes related to Venezuela becoming
highly inflationary economy and $3,228 tax benefit from an
international income tax audit settlement
Herbalife Ltd.
Supplemental Schedule
Non-GAAP Financial Measures
(In thousands, except per share data)
(Unaudited)
Quarter Ended 12/31/2009
Reported Adjusting Adjusted
(GAAP) Items (Non-GAAP)
Net Sales $ 630,871 $ 630,871
Cost of Sales 136,515 (12,544 ) (1) 123,971
Gross Profit 494,356 12,544 506,900
Royalty Overrides 204,580 204,580
SGA 205,691 $ 2,368 (2) 208,059
Operating Income 84,085 10,176 94,261
Interest Expense - net 1,016 1,016
Income before income taxes 83,069 10,176 93,245
Income Taxes 27,413 4,099 (3) 31,512
Net Income $ 55,656 $ 6,077 $ 61,733
Diluted EPS $ 0.88 $ 0.10 $ 0.98
1 Related to incremental U.S. dollar costs of imports into Venezuela
at the unfavorable parallel market exchange rate rather than the
official currency exchange rate
2 Related to foreign exchange gain for Venezuela resulting from
receipt of U.S. dollars approved by CADIVI at the official exchange
rate
3Includes $3,562 tax benefit of Venezuela items and tax benefit of
$537 from an international income tax audit settlement
Herbalife Ltd.
Supplemental Schedule
Non-GAAP Financial Measures
(In thousands, except per share data)
(Unaudited)
Twelve Months Ended 12/31/2009
Reported Adjusting Adjusted
(GAAP) Items (Non-GAAP)
Net Sales $ 2,324,577 $ 2,324,577
Cost of Sales 493,134 (12,544 ) (1) 480,590
Gross Profit 1,831,443 12,544 1,843,987
Royalty Overrides 761,501 761,501
SGA 773,911 $ 257 (2) 774,168
Operating Income 296,031 12,287 308,318
Interest Expense - net 5,103 5,103
Income before income taxes 290,928 12,287 303,215
Income Taxes 87,582 8,536 (3) 96,118
Net Income $ 203,346 $ 3,751 $ 207,097
Diluted EPS $ 3.22 $ 0.06 $ 3.28
1 Related to incremental U.S. dollar costs of imports into Venezuela
at the unfavorable parallel market exchange rate rather than the
official currency exchange rate
2 Includes $1,297 restructuring charges, $814 expense from an
international income tax audit settlement and $2,368 foreign exchange
gain for Venezuela resulting from receipt of U.S. dollars approved by
CADIVI at the official exchange rate
3 Includes $4,852 tax benefit from expiration of certain statutes of
limitation, tax charge of $277 from an international income tax audit
settlement, $399 tax benefit of restructuring charges and $3,562 tax
benefit of Venezuela items
The following is a reconciliation of total long-term debt to net debt:
12/31/2010 12/31/2009
Total long-term debt (current and long-term $ 178,166 $ 250,333
portion)
Less: Cash and cash equivalents 190,550 150,801
Net debt $ (12,384 ) $ 99,532
Source: Herbalife Ltd.
Released Feb 22, 2011 • 4:10pm EST